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ABSTRACT
Background. Amphibians are declining at an alarming rate, and one of themajor causes
of decline is the infectious disease chytridiomycosis. Parasitic fungal sporangia occur
within epidermal cells causing epidermal disruption, but these changes have not been
well characterised. Apoptosis (planned cell death) can be a damaging response to the
host but may alternatively be a mechanism of pathogen removal for some intracellular
infections.
Methods. In this study we experimentally infected two endangered amphibian species
Pseudophryne corroboree and Litoria verreauxii alpina with the causal agent of chytrid-
iomycosis. We quantified cell death in the epidermis through two assays: terminal
transferase-mediated dUTP nick end-labelling (TUNEL) and caspase 3/7.
Results. Cell death was positively associated with infection load and morbidity
of clinically infected animals. In infected amphibians, TUNEL positive cells were
concentrated in epidermal layers, correlating to the localisation of infection within
the skin. Caspase activity was stable and low in early infection, where pathogen loads
were light but increasing. In animals that recovered from infection, caspase activity
gradually returned to normal as the infection cleared. Whereas, in amphibians that did
not recover, caspase activity increased dramatically when infection loads peaked.
Discussion. Increased cell death may be a pathology of the fungal parasite, likely
contributing to loss of skin homeostatic functions, but it is also possible that apoptosis
suppression may be used initially by the pathogen to help establish infection. Further
research should explore the specific mechanisms of cell death and more specifically
apoptosis regulation during fungal infection.
Subjects Ecology, Mycology, Veterinary Medicine, Histology
Keywords Apoptosis, Caspases, Chytridiomycosis, TUNEL, Wildlife disease
INTRODUCTION
Amphibians globally are experiencing the greatest loss in biodiversity of all vertebrate taxa
(Stuart et al., 2004). One of the major causes of decline is disease, specifically a fungal par-
asite, Batrachochytrium dendrobatidis, Bd (Skerratt et al., 2007), which causes the fatal skin
disease chytridiomycosis. So far, solutions for minimising Bd related mortality are lacking
and research devoted to improving survival rates within these declining populations will
be key to conservation management.
How to cite this article Brannelly et al. (2017), Epidermal cell death in frogs with chytridiomycosis. PeerJ 5:e2925; DOI
10.7717/peerj.2925
Although chytridiomycosis is a superficial epidermal infection, disruption to skin func-
tion causes severe loss of electrolytes leading to cardiac failure (Voyles et al., 2009). Global
research into the host-parasite dynamics has shown that resistance varies among species,
populations and individuals. After demonstrating that vaccination is unlikely to be effective
at substantially reducing mortality (Cashins et al., 2013; McMahon et al., 2014), the focus
has been on identifying key immune factors that may then be selected for in breeding
programs (Scheele et al., 2014; Skerratt et al., 2016). While various potential immune
mechanisms—such as antimicrobial peptides (Woodhams et al., 2006a; Woodhams et al.,
2006b), cutaneous bacterial flora (Woodhams et al., 2007), immune cell receptors (Savage
& Zamudio, 2011; Bataille et al., 2015) and lymphocyte activity (Fites et al., 2014)—are
currently being studied, few studies have explored cell death and apoptosis in the skin as
an immune mechanism.
Apoptosis is a controlled process resulting in programmed non-inflammatory cell death
via the action of caspase proteases and phagocytosis (Fink & Cookson, 2005). It is vital to
tissue growth anddifferentiation, and is associatedwith elimination of damaged cells and in-
fectious agents, particularly intracellular pathogens (Kim et al., 1998;Barber, 2001;Nogueira
et al., 2009; Lamkanfi & Dixit, 2010; Ashida et al., 2011). Hosts utilise apoptosis of infected
cells to block replication of pathogens, resulting in clearance of the infection. However,
some pathogens can evade the immune system by hijacking the host’s apoptotic machinery:
they produce apoptosis inhibitors in order to aid in replication and survival, while others
can induce apoptosis to facilitate dissemination or destroy host immune cells (Weinrauch
& Zychlinsky, 1999; Hasnain et al., 2003; Faherty & Maurelli, 2008; Hacker, 2009; Lamkanfi
& Dixit, 2010). Therefore, the ability of the host and pathogen to control apoptosis can
greatly influence disease severity and clinical outcomes.
Apoptosis, and more broadly general cell death, may be a pathology of Bd infection
in amphibians, as characteristic epidermal degenerative changes have been observed in
Bd-infected frogs by electron microscopy (Berger et al., 2005; Pasmans et al., 2010). Disso-
ciation of epidermal intracellular junctions triggering detachment-induced apoptosis was
observed when skin explants were treated with zoospore supernatants in vitro (Brutyn et al.,
2012).
Transcriptomic studies have shown apoptosis pathways are upregulated in skin of resistant
and susceptible frog species (Ellison et al., 2014). Amphibian splenocytes also undergo
apoptosis when treated with Bd sporangial (but not zoospore) supernatants in in vitro
assays, associated with increased intrinsic, extrinsic and effector caspase activity in these im-
mune cells (Fites et al., 2013). Despite the evidence to suggest that Bd can induce apoptosis
of specific cells in vitro, there are no studies that use direct and quantifiable assays, or that
explore apoptosis mechanisms during progress of an infection in vivo. Furthermore, it is
not known whether the host can effectively use apoptosis as an immune defence against
chytridiomycosis.
The aim of this study was to quantify levels of cell death and apoptosis in amphibian skin
during experimental infection of two species threatened by chytridiomycosis, the alpine tree
frog, Litoria verreauxii alpina, and the southern corroboree frog, Pseudophryne corroboree.
To ensure accurate measurement of the apoptotic effect, two methods of detection were
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utilised (Galluzzi et al., 2009): caspase 3/7 protein assay, and terminal transferase-mediated
dUTP nick end-labeling (TUNEL) in situ assay. The caspase 3/7 assay quantifies the activity
of effector caspases activated by both the intrinsic and extrinsic apoptosis pathways, while
the TUNEL assay detects DNA fragmentation characteristically caused by cell death such as
apoptosis, necrosis and pyroptosis (Kelly et al., 2003). This exploratory project characterised
measures of cell death and apoptosis in epidermal cells. We tested the hypothesis that cell
death and apoptosis was correlated with infection intensity and host survival in order to
explore if cell death is amechanism of disease resistance or cutaneous pathology. If infection
load is positively correlated with cell death, this could reflect either an effective immune
response or pathology of disease. If a high level of cell death is a pathology of disease
we expect that high cell death to be present on animals that succumb to disease. But if
apoptosis was a useful immune response, we predict that animals that cleared infection
would have higher rates initially or at the time of Bd reductions.
MATERIALS AND METHODS
Study organisms
Litoria verreauxii alpina that were excess to a reintroduction trial (a total of 300 from two
different populations) were obtained from Taronga Zoo, Sydney, and were part of a larger
experiment (Brannelly et al., 2016b; Brannelly et al., 2016c). Litoria v. alpina are a declining
anuran endemic to the Australian Alps in New South Wales and Victoria, Australia. The
species is highly susceptible to Bd, which is the primary cause of decline (Bataille et al.,
2015; Brannelly et al., 2015b; Brannelly et al., 2016a). The animals sexually mature at 2 years
and these animals ranged from two to three years old and were captive raised under strict
quarantine protocols and had never been exposed to Bd. Animals were housed individually
in 300× 195× 205mmterrariumwith gravel substrate, at a room temperature of 18−20 ◦C.
They were fed ad libitum three times weekly with juvenile (10 mm) crickets (Acheta
domestica) (dusted with amphibian vitamins and gut-loaded). Animals were misted twice
daily for 60 s with reverse osmosis water. Temperature and humidity were monitored daily.
Pseudophryne corroboree were excess to a breeding program at the Amphibian Research
Centre, Pearcedale, Victoria, Australia (a total of 120 adult animals from five different
populations). These animals were 5–8 years old and part of a larger research experiment
(Brannelly et al., 2016b; Brannelly et al., 2016c). Pseudophryne corroboree are functionally
extinct in the wild, and highly susceptible to Bd (Brannelly et al., 2015a; Brannelly, Skerratt
& Berger, 2015). These animals were housed in the same conditions as above but on a paper
towel substrate that was changed once a fortnight.
Inoculation
Animals were allowed to acclimate to their new environment for at least seven days. All
animals were tested for Bd infection prior to the start of the experiment (see ‘Testing for
Bd’ below) and all were found to be negative. Cultures of Bd were harvested from tryptone,
gelatin hydrolysate, lactose (TGhL) agar plates after incubation at 23 ◦C for 5 days. Three
millilitres of artificial spring water was poured onto the plates and incubated for 10 min to
allow zoospores to be released from zoosporangia to create the inoculum. Inoculum was
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Table 1 Sample sizes for all animals inoculated, and the subset of animals used in each assay.
Species Assay Total animals Subset used
Inoculated Control Bd+ Control Bd+ early Bd− cleared
Litoria v. alpina TUNEL 6 7 2 2
Caspase 27 8 4 8 11
Pseudophryne corroboree TUNEL 13 6 10 5 3
poured off the plates and zoospores were counted using a hemocytometer and then diluted
with artificial spring water to achieve the appropriate concentration as described below
Samples sizes for each inoculation found in Table 1. Note that the inoculation strain used
for obtaining infected samples for the TUNEL assay in L. v. alpina differs from the others,
and was used to obtain higher infection rates
TUNEL assay
Litoria v. alpina used in the TUNEL assay, were inoculated with aNew SouthWales strain of
Bd (WastePoint-L. v. alpina-2013-LB2, Passage number 1). Animals were inoculated with
5×105 zoospores in 10 mL of inoculum and held in inoculation containers for 24 h.
Pseudophryne corroboree were inoculated with a New South Wales strain of Bd
(AbercrombieR-L.booroologensis-2009-LB1, Passage number 11). Animals were inoculated
with 1× 106 zoospores by applying 3 mL of inoculum onto the venter. Animals were
placed in individual 40 mL containers for 6 h, and then transferred back into their terraria.
Control animals were mock-inoculated using uninfected agar plates (see Table 1 for sample
sizes).
Caspase assay
Litoria v. alpina used in the caspase 3/7 assay were inoculated following the same protocol
as for P. corroboree above. Control animals were mock-inoculated using uninfected agar
plates.
Data collection
Each week animals were swabbed for Bd infection (see below), weighed to the nearest 0.01
g with a digital scale, and measured snout to venter (SVL) to the nearest 0.1 mm with dial
callipers. Animals were euthanized with an overdose ofMS-222 when severe clinical signs of
chytridiomycosis were displayed (irregular skin slough, leg redness, inappetence, lethargy,
loss of righting reflex) and animals appeared moribund in accordance with animal ethics.
Clinical signs of disease were seen by L. v. alpina from days 52–70 and by P. corroboree from
days 45–83. The experiment ended on day 90, when all control and remaining exposed
animals were euthanized.
TUNEL assay
In order to explore cell death in the epidermis of animals that experienced a light infection,
3 P. corroboree were euthanized on day 21 post inoculation. This group of animals will
hereby be called ‘‘Early Bd+’’.
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Caspase assay
For the L. v. alpina in the caspase 3/7 assay, toe clips were removed from each animal at
the second phalange and immediately frozen at −80 ◦C. Toe clips were removed weekly
until week 3, and then fortnightly until the end of the experiment.
Testing for Bd
We tested for Bd infection by using qPCR on skin swabs (Boyle et al., 2004). We used a
standard protocol that involved 45 strokes per animal with a sterile rayon-tipped swab
(MW-113;MedicalWire & Equipment), five on themiddle of the venter, five on each side of
the venter, five on each thigh, and five on the ventral surface of each hand and foot. The swab
was gently rotated during and between strokes to ensure the greatest amount of DNA was
gathered on the swab. GenomicDNAwas extracted from the swabs using the PrepmanUltra
kit and 2 min of bead beating to break apart the fungal cell walls. The extract was analysed
using quantitative PCR following Boyle et al. (2004), in singlicate (Kriger, Hero & Ashton,
2006; Skerratt et al., 2011; Brannelly et al., 2015b) with a positive and negative control, and
a series of dilution standards (made in house from a local Australian Bd isolate) in order
to determine zoospore equivalents (ZE) per sample.
TUNEL assay
Upon euthanasia, a subset of L. v. alpina animals (n= 2 control and n= 2 exposed), and
P. corroboree (n= 5 Bd− control, n= 3 Early Bd+ animals with light Bd infection, and
n= 10 Late Bd+ animals at morbidity) (Table 1) were dissected for skin samples (one
sample each from the dorsum, venter and thigh, although no thigh skin was taken for the
P. corroboree Early Bd+ animals because that skin was used in a transcriptomics project).
Skin was fixed in 4% phosphate buffered formaldehyde for 2 h, and tissues were transferred
to 80% ethanol prior to embedding in paraffin wax for histological preparation. Routine
histological techniques were used to prepare the tissues for light microscopy following
standard methods (Woods & Ellis, 1994). Tissues were dehydrated in a graded series of
ethanol, cleared with xylene, and embedded in paraffin (all three skin samples in one block).
Tissues were serially sectioned at 5 µm, affixed to hydrophilic glass slides with four serial
histosections per slide. Three slides were made per tissue section from the three different
areas of the skin per animal and stained in the following order: the first slide was stained
with hematoxylin followed by eosin counterstaining (H&E). The next two slides were
processed with TUNEL assay following manufacturer’s instructions (ApopTag R© Red In
Situ Apoptosis Detection Kit, Merck Millipore), followed with a DAPI counterstain. The
first of the slides used in TUNEL were the assay slides (where we assessed number of
apoptotic cells) and the second slide was a quality control test (with two histosections used
as a positive control and the last two as a negative control). For the TUNEL assay slides,
cells were counted using fluorescent microscopy at 200× magnification under DAPI fluo-
rescence, then the same section counted for TUNEL positive staining, indicating apoptotic
cells. At least 100 cells per animal were counted per skin section. To reach 100 cells, all cells
were counted within a field of view. If a field of view contained less than 100 cells, another
field of view was selected and counted entirely. The H&E stained histosections were used to
ensure the site of infection were the areas used in the TUNEL assay to count apoptotic cells.
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Caspase 3/7 assay
Frozen toe clip samples were extracted in 100 µL Buffer A (25 mM HEPES pH 7, 5 mM
MgCl2) with two 3.2 mm stainless steel beads in a 1.5 mLmicrotube. Samples were lysed by
four cycles of 1min bead beating followed by 3min on ice. Samples were then centrifuged at
4 ◦C for 5min at 12,000× g . Supernatant was collected and used in the assay. As toe samples
were very small, reaction volumes were kept to a minimum. Protein concentration of each
toe was determined to standardise the sample sizes for the caspase assay. Concentration
was quantified using the Bradford assay, with 10 µL Coomassie Bradford reagent (Pierce)
and 10 µL of protein extract mixed and incubated at room temperature for 2 min. The
samples and BSA standards were run in duplicate or triplicate in a 384 well plate, and the
absorbance wasmeasured at 595 nm (POLARstar Omega; BMGLabtech). Caspase 3/7 assay
(Caspase Glo R© 3/7; Promega) was performed in triplicate in a 384 well plate with 10 µL
Caspase Glo reagent and 10 µL protein extract. After mixing, the reactions were incubated
in the dark at room temperature for 30 min, after which luminescence was measured (PO-
LARstar Omega; BMG Labtech) (caspase activity). All samples of animals that had severe
clinical signs of chytridiomycosis (n= 4), all control samples (n= 8), and a randomised
subset of animals that cleared Bd infection (n= 11) were analysed. Only samples through
week 7 post inoculation were run, which is the last sampling point where all animals
with severe infection were alive, in order to ensure statistical validity of the Bd+ animals.
Statistical analysis
Infection load
Infection loads, or ZE determined from qPCR, of animals were log base 10 transformed.
Clinical infections were defined as showing signs of disease with high Bd loads by qPCR
(i.e., greater than 1,000 ZE). An animal was considered cleared of infection if the animal was
qPCR negative for Bd for at least three weeks. For the L. v. alpina involved in the caspase
trial, we defined three infection statuses: control animals, animals that demonstrated severe
clinical signs (Bd+) and animals that cleared Bd infection (Bd cleared) animals. Bd+ ani-
mals were comparedwithBd cleared animals in infection intensity using linearmixed effects
models; where individual was repeated, the response variable was infection intensity, and
fixed effects were week, infection status and week*infection status. Overall infection load
for each group (L. v. alpina caspase trial: Bd cleared and Bd+; P. corroboree TUNEL assay:
Early Bd infection and Late Bd infection) were determined by averaging infection load at
date of death for P. corroboree and infection load through all time points for L. v. alpina
and determining the effect size using Cohen’s d statistic (Altman, 1991) in which a large
effect is when d > 0.8. Cohen’s d statistic was calculated in Microsoft Excel.
TUNEL assay statistics
The proportion of TUNEL positive cells to TUNEL negative cells in infected animals and
control animals was compared using Pearson’s Chi-Squared test for association. Each tissue
type (dorsal, ventral and thigh skin) was analysed as a separate chi-squared test. Following
the association test, the strength of association was determined by an odds ratio analysis
for TUNEL positive and negative cells of each tissue type. The odds ratio analysis was
performed in Microsoft Excel (Altman, 1991). Sample sizes for L. v. alpina were too small
Brannelly et al. (2017), PeerJ, DOI 10.7717/peerj.2925 6/20
to determine significance (n= 2 Bd+, n= 2 Bd cleared), so trends were noted following
the chi-squared and odds ratio tests, while significance was determined in the P. corroboree
samples (n= 5 control, n= 3 Early Bd+ and n= 10 Late Bd+).
Caspase assay statistics
Caspase 3/7 activity was calculated as caspase activity over protein concentration per
sample, and then log base 10 transformed. Weeks 1, 2, 3, 5 and 7 were analysed for the
three infection statuses, control, Bd+ and Bd cleared Caspase activity was assessed using
linearmixed effects models; where the response variable was caspase activity, individual was
repeated, andweek, infection status andweek*infection status were fixed effects. If infection
status*week was a significant interaction we used one-way ANOVAs and Bonferroni’s post
hoc test to determine in which specific weeks the infection status groups differed in caspase
activity. To determine the change in caspase activity each week, linear mixed effects models
were usedwith the sameparameters as above, except the response variablewas change in cas-
pase activity. To determine which weeks change in caspase activity varied between groups,
one-way ANOVAs were performed using Bonferroni’s post hoc test. The association be-
tween caspase activity and infection intensity was performed using a linear regression in Bd
inoculated animals only. In order to determine if week or status had an effect a general linear
model (GLM) was performed; where log10(Caspase) was compared with infection status,
week and log10(ZE). All analyses were performed using SPSS (v21) unless otherwise stated.
Animal ethics
Animal ethics was approved by James Cook University in applications A1897 and A2171
for L. v. alpina and A1875 for P. corroboree.
RESULTS
Bd Infection
Infection progressed as expected for the TUNEL assay individuals: all P. corroboree animals
inoculated with Bd developed clinical disease, except for the three individuals euthanized
at day 21 and represented as Early Bd+. Animals with clinical disease (Late Bd+) survived
between 22 and 83 days post inoculation (average of 59.6 days) and their average infection
load at date of death was a near to 1,000 fold higher infection load (793.3 time increase
in ZE) than the infection load of animals with light infection loads (Early Bd+), which
were euthanized on day 21 post inoculation (Late Bd+= 5.19 Log10(ZE) ± 0.34; Early
Bd+= 2.29 Log10(ZE) ± 0.89; d = 3.04). In Bd inoculated L. v alpina animals (n= 6) all
developed clinical chytridiomycosis and survived 39–63 days post inoculation (average of
52.7 days) and their average infection load at date of death was 3.57 Log10(ZE) ± 0.75.
Of the 27 L. v. alpina inoculated in the caspase infection experiment, all became infected,
but only four developed severe chytridiomycosis. The first animal died on day 58 after inoc-
ulation and the last on day 71 (average of 63 days). All animals that did not develop severe
chytridiomycosis had cleared infection by week 12 post-inoculation. The factors that
influenced infection load were week, infection status and week*status (linear mixed effects
model: week, F11= 5.425, p< 0.01; infection status, F1= 23.763, p< 0.01; week*status,
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Figure 1 Infection intensity over the course of the experiment in animals that succumbed to chytrid-
iomycosis (Bd+) (n = 4) and those that cleared infection (Cleared) (n = 23) after week 12 for the
Litoria verreauxii alpina in the caspase trial. Infection intensity is log10(ZE), and error bars indicate
standard error.
F9= 3.071, p< 0.01) (Fig. 1). Litoria v. alpina animals that developed severe chytridiomy-
cosis had, on average of all time points, a near 200× higher infection load than animals
that cleared infection (194 time increase in ZE) (Died= 3.09± 1.22 Log10(ZE); Cleared=
0.80 ± 1.28 Log10(ZE)) (Cohen’s d statistic = 1.30).
TUNEL assay
There was more cell death in infected animals compared with uninfected animals in both
L. v. alpina and P. corroboree. The location of TUNEL positive cells in situ differed in Bd+
and control animals of both species. In control animals, low levels of background TUNEL
positive cells were evenly distributed throughout the epidermal and dermal layers of the
skin (Fig. 2A), but in the Bd+ animals, the TUNEL positive cells appeared more frequently
in the epidermis (Fig. 2B). On microscopic examination of the H&E stained sections,
clumped Bd sporangia were observed to be scattered through the ventral and thigh areas of
skin, but none were seen in the dorsum of either species (Late Bd+), or in the P. corroboree
with light infections (Early Bd+). TUNEL positive cells appeared to be more concentrated
at infection foci (Fig. 2C), but were also more widespread over the epidermis and in deeper
epidermal layers than Bd.
In P. corroboree, all three skin types showed an increase in TUNEL positive cells when
infected with Bd in both early and late infection (Fig. 3A). In the thigh skin, Late Bd+
animals had 12.01 (95% CI [4.92–26.30]; Odds Ratio: Z = 5.46,p< 0.01) times more
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Figure 2 Terminal transferase-mediated dUTP nick end-labelling (TUNEL) in situ assay of infected
and uninfected animals. (A) Bd− control thigh skin section of Pseudophryne corroboree, and (B) Bd+
thigh skin section of P. corroboree stained by in situ TUNEL assay. The blue is DAPI staining indicating
nuclei of the cells, and the red is the rhodamine stain, which indicates DNA fragmentation characteristi-
cally caused by apoptosis. (continued on next page. . . )
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Figure 2 (. . .continued)
The yellow arrow indicates the position of the Bd cluster seen in (C). (C) P. corroboree section of thigh
skin stained with H&E. The H&E section is serial to (B). There is a cluster of empty Bd sporangia (arrow)
and a few dark immature sporangia near the skin surface. For (A–C) the epidermis is at the top of the pho-
tos. Comparing (B) and (C) shows that the rhodamine stained epidermal cells are concentrated around
and below the cluster of Bd and where skin damage is visible such as micro-vesicle formation between
basal epidermal cells. 400×magnification and the scale bar indicates 0.03 mm.
TUNEL positive cells than control animals (Pearson’s chi-squared: χ21 = 44.30, p< 0.01).
In the venter skin, Late Bd+ animals have 22.31 (95% CI [5.25–94.82]) times more
TUNEL positive cells than control animals (Odds Ratio: Z = 4.21, p< 0.01) and 2.16
(95% CI [1.15–4.03]) times more TUNEL positive cells than Early Bd+ animals (Odds
Ratio: Z = 4.21, p< 0.01). The Early Bd+ animals had 10.33 (95% CI [2.37–45.067])
times more TUNEL positive cells than control animals in the venter skin (Odds Ratio:
Z = 3.11, p< 0.01; Pearson’s chi-squared: χ22 = 33.45, p< 0.01). In the dorsal skin, the
Late Bd+ animals had 14.38 (95% CI [3.32–62.24]) times more TUNEL positive cells
than control animals (Odds Ratio: Z = 3.57, p< 0.01) and Early Bd+ animals had 19.88
(95% CI [4.67–84.20]) times more TUNEL positive cells than control animals (Odds Ratio:
Z = 4.05, p< 0.01; Pearson’s chi-squared:χ22 = 29.45, p< 0.01) but there was no difference
observed in TUNEL positive cells of the dorsum in Early and Late Bd+ animals (Fig. 3A).
Due to the small sample sizes for infected and control L. v. alpina (n= 2 for each group),
only trends could be determined. But there was a higher proportion of TUNEL positive
cells in the venter and the thigh skin with no observable difference in the dorsal skin (Fig.
3B) (Pearson’s chi-squared: Venter skin, χ21 = 5.38, p= 0.02; Thigh skin, χ21 = 9.198,
p< 0.01, Dorsal skin: χ21 = 1.694, p= 0.19).
Caspase 3/7 assay
Caspase activity was positively correlated with infection load in inoculated L. v. alpina
animals (Pearson’s correlation: R64= 0.463, p< 0.01; Linear Regression: F1,62= 16.943,
p< 0.01) (Fig. 4). However, there was no overall difference between the animals that cleared
infection (Bd cleared) and those that developed severe chytridiomycosis (Bd+) (GLM:
F1= 0.079, p= 0.685), or between weeks (GLM: F4= 0.226, p= 0.717).
There was a difference in total caspase activity over time among the three groups (control,
Bd + and Bd cleared). The three groups differed over week and week*disease status (Linear
mixed effects model: week, F4 = 11.974, p< 0.01; week*status, F8 = 2.139, p= 0.037).
There was no effect of week on the control group (Mixed model: F4= 2.463, p= 0.069)
(Fig. 5A). At week 3, there was 48.36% less log10 caspase activity in the Bd+ compared with
the control animals, and 41.63% less activity in the Bd cleared animals compared with the
control animals (ANOVA: F2,18= 5.512, p= 0.014; Bonferroni Post-Hoc: control v Bd+,
p= 0.046, d = 1.408; control v Bd cleared, p= 0.028, d = 0.923).
When investigating the change in caspase activity each week over the first seven weeks
post inoculation, therewas a difference among the three groups, withweek andweek*disease
status as important factors (Mixed Model: week, F3 = 5.764, p< 0.01; week*status,
F6= 3.044, p= 0.01), but there was no effect of week on the control group (Mixed model:
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Figure 3 The proportion of TUNEL positive (TUNEL+) cells per skin type. (A) The proportion of
TUNEL positive apoptotic cells per skin type in P. corroboree with light infection intensity (Early Bd+, n=
3), animals that succumbed to disease (Late Bd+, n= 9) and control animals (n= 10). (continued on next
page. . . )
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Figure 3 (. . .continued)
Error bars indicate 95% confidence intervals of a proportion and ∗ indicates a significant increase in apop-
totic cell proportions where (∗a) indicates a difference between control and Late Bd+, (∗b) indicates a
difference between control and Early Bd+, and (∗c) indicates a difference between Early Bd+ and Late
Bd+ skin samples. There was no thigh skin sample taken for the Early Bd+ group. (B) The proportion of
TUNEL positive apoptotic cells in L. v. alpina for control animals (n= 2) and Bd+ clinically infected ani-
mals (n= 2), where each individual is represented as a separate bar.
Figure 4 The correlation between infection intensity, Log10(ZE), and caspase 3/7, Log10(Caspase) of in-
oculated L .v. alpina over the course of the experiment. The correlation between infection intensity and
caspase activity is 0.463, and the trend line has an equation of y = (0.229)x+0.939. There is no difference
between Bd+ animals that succumbed to Bd infection (n= 4) and animals that were inoculated and then
cleared infection (n= 23), or between weeks of infection.
F3= 20.004, p= 0.371) (Fig. 5B). The change in caspase activity between weeks 3 and 5
differed significantly among the three groups, with the Bd+ animals increasing in caspase
3/7 activity 15.35 times the change in control animals, and 2.162 times the change in Bd
cleared animals (ANOVA: F2,25= 10.65,p< 0.01; Bonferroni Post-Hoc: control v Bd+,
p< 0.01, d = 2.519; Bd+ v Bd cleared, p< 0.01, d = 1.241).
DISCUSSION
In this study we explored cell death and apoptosis in the epidermis of Bd susceptible species
as a potential mechanism of disease resistance or cutaneous pathology of chytridiomycosis.
We tested the hypothesis that cell death and apoptosis were correlated with infection
intensity and host survival, and further we hypothesized that if apoptosis was a useful
immune response, animals that cleared infection would have higher rates initially or at the
time of Bd reductions. We found that cell death does indeed increase drastically during
Brannelly et al. (2017), PeerJ, DOI 10.7717/peerj.2925 12/20
Figure 5 Caspase 3/7 activity through week 7 for each group of L. v. alpina. Caspase activity is defined
as the lumiunecence reading controlled for by protein concentration per sample and then log base 10
transformed. The three experimental groups were defined as: Bd+ that succumbed (Bd+, n= 4), controls
(n = 8) and Bd inoculated that cleared infection (Cleared, n = 23). (A) The caspase activity (Log10 trans-
formed) for each group per week. (B) The weekly change in caspase activity (Log10 transformed) for each
group. Error bars indicate standard error. ∗a indicates the Bd+ group differed significantly from the con-
trol group at that week, ∗b indicates the cleared group differed from the control group, and ∗c indicates
that the Bd+ group differed from the Cleared group.
Brannelly et al. (2017), PeerJ, DOI 10.7717/peerj.2925 13/20
clinical chytridiomycosis as demonstrated through the in situTUNEL assay. Because caspase
3/7 levels were correlated with infection load, this suggests that cell death is pathology of
Bd. However, because animals that cleared infection had relatively low caspase levels, and
did not differ from the animals that eventually developed chytridiomycosis in early weeks
following exposure, this does not support our hypothesis that cell death and apoptosis was
a useful immune response to Bd infection.
We found an increase in cell death in the epidermis of infected P. corroboree and L. v.
alpina compared to the control animals using in situ TUNEL assay, consistent with the
apoptosis suggested previously bymicroscopy (Berger et al., 2005; Pasmans et al., 2010;Bru-
tyn et al., 2012) TUNEL positive cells were located near the site of infection, and occurred
on the ventral surface of the animal (thigh and venter skin); but not on the dorsum in L.
v. alpina. However, Pseudophryne corroboree demonstrated an increase in TUNEL positive
cells as infection progressed in all skin tissues. The location of TUNEL positive cells within
the epidermal layers, and their increase over time, is consistent with infection of Bd being
the cause of epidermal cell death.
Our qualitative observation of more TUNEL positive cells in the venter and thigh skin
of Bd infected animals is consistent with the pattern of Bd distribution noted in other
amphibian species. One study that measured Bd infection over the body in two Australian
hylids (Litoria caerulea and Litoria genimaculata), showed the dorsum was uninfected or
lightly infected, with higher loads on abdomen and thighs (Berger, Speare & Skerratt, 2005b;
North & Alford, 2008). We did not quantify Bd loads at each skin site in our two species, but
noted a similar pattern by histology with no sporangia seen on dorsal skin. In P. corroboree
it was unexpected that increased cell death occurred in dorsal skin. This site distribution,
together with the diffuse staining in infected sites, shows that cell death is not localised to
infected and adjacent cells and may be associated with diffusion of pro-apoptotic factors
from the host or pathogen.
For effector caspase 3/7 activity in L. v. alpina,Bd exposed animals initially demonstrated
stable and low levels of apoptosis early in infection (1–3 weeks) despite detectable Bd loads
(Figs. 1 and 5A). This observed lower caspase activity early in infection suggests that Bd
may suppress apoptosis in order to establish infection, which is particularly prominent at
week 3 after inoculation. If the host is able to overcome infection, the caspase 3/7 levels
gradually rise and return to normal. However, in animals that eventually displayed clinical
signs of chytridiomycosis there was then a rapid and sustained increase of caspase activity
over weeks 3–5 (Fig. 5B), which correlates with the timing of high pathogen burden (Fig. 1).
This rapid increase is not observed for animals that clear infection, suggesting that rapidly
increasing apoptosis was not beneficial and may be a mechanism of pathogenesis by Bd
because it was correlated with an increase in infection load and mortality. It remains
possible that increased apoptosis is a failed host response to higher burdens in these
individuals.
Such pathology of initial suppression of apoptosis followed by a rapid increase has been
witnessed in other pathogens such as Shigella flexneri, a bacterium causing diarrhea in
humans. The pathogen uses a dual cell death control strategy by producing cytoprotective
factors early in infection to aid in replication, followed by necrotic cell death signals later in
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the infection to enable transmission and host tissue damage (Carneiro et al., 2009). While
the apoptotic effect of Bd on amphibian lymphocytes in vitro is known (Fites et al., 2014),
host and pathogen mechanisms for this phenomenon are still unclear. Therefore, further
experiments are required to confirm whether Bd can stimulate or suppress apoptosis in
epidermal cells. Cell-specific effects are seen in other pathogens, for example, Salmonella en-
terica induces cell death in macrophages (Fink & Cookson, 2006), but suppresses apoptosis
in epithelial cells (Knodler, Finlay & Steele-Mortimer, 2005), showing that a pathogen can
behave differently in different cell types.
Interestingly, while there is evidence of a higher proportion of epidermal cell death in in-
fected animals at morbidity through the TUNEL endpoint assay, we observed no difference
in caspase 3/7 activities between Bd+ and control animals at week 7. This discrepancy may
be explained by the two different measures of cell death Caspase 3/7 is an effector enzyme
integral to the caspase pathway, but other enzymes within the caspase pathway may also
be effective indicators of apoptosis. For example, caspase 1 is involved in the inflammatory
response in vivo. Furthermore caspase 8 (extrinsic pathway) and 9 (intrinsic pathway) are
both known to be active in response to Bd in lymphocytes in vitro (Fites et al., 2013), and
further work should explore the levels of these caspases in order to separate activation
in the intrinsic and extrinsic pathways. Furthermore, the last caspase data point was
measured at week 7, which is 1–3 weeks prior to the frogs becoming moribund when
TUNEL assays were conducted. Therefore, the caspase activity may have increased
even more later in infection. Site specific apoptosis may also affect the caspase 3/7
results, as this time course experiment required sampling of toes rather than body skin.
It must also be noted that while the TUNEL assay is most often used to explore apoptotic
cells, it measures DNA damage, which can be caused by other cell death mechanism like
necrosis and pyroptosis (Kelly et al., 2003). Therefore, the increase in assay positive cells at
morbidity may be caused by non-apoptotic cell death pathways that do not involve caspase
enzymes. Non-caspase mediated cell death might explain the pattern of increased positive
TUNEL assay in the Early Bd+ P. corroboree, which was not mirrored in the caspase assay of
L. v. alpina. Alternatively the two speciesmight exhibit different host-pathogen interactions.
This study investigating the role of apoptosis through in situ TUNEL assay and caspase
3/7 presence in the epidermis demonstrates only the initial stages of exploring apoptosis in
vivo. The early signs of apoptosis suppression in exposed animals suggest that suppression
of apoptosis may be used initially by the pathogen in order to establish infection. Also,
the steep increase in apoptosis and cell death in animals that succumbed to disease could
explain the disruption to epidermal ion transport that ultimately causes cardiac arrest in
clinical chytridiomycosis, although further work on the causal mechanisms of pathogenesis
is needed. While more research is needed to determine how apoptosis influences disease
outcomes in hosts able to clear infection, these results suggest that apoptosis can be
important in the pathogenesis of Bd.
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